The Power of An Expert Partnership in Devices for Robotic-Assisted Surgeries Key Takeaways: Ensure device integrity with a packaging partner specializing in sterility, integrity, and rigorous testing to meet regulatory compliance standards. A partner for in-process testing can improve cost efficiency and reduce lead times, enabling quicker turnaround and faster time-to-market. Expanded…
Building Resiliency for the Next Big Supply Chain Interruption Supply chain resilience continues to be the headline story of 2021, in the orthopedic medical device industry as well as across industries. As we look to the post-COVID period, what has the orthopedic industry learned about managing complexity, forecasting, sourcing, risk, and supply chain…
Industry Q&A: Common Pitfalls of Orthopedic Robotic Assisted Surgery Product Launches Robotic assisted surgery products were already on the ascent in the orthopedic space well before COVID-19, but the pandemic may just prove to be a booster for their continued adoption and growth. Stryker’s acquisition of Mako Surgical in 2013 paved…
Three Reasons Reverse Logistics is Mission-critical for OEMs Over the last year, we’ve confronted a new reality in a world that changed rapidly, sometimes daily, for the medtech industry. Supply chain disruption unfolded across the globe early, with widespread ramifications for materials, labor and production. According to recent research by EY, two-thirds of medtech companies…
Confronting the New Post-COVID Complexities of the Orthopedics Industry The orthopedic industry is highly complex and fiercely competitive, which puts significant pressure on OEMs. A rapidly evolving market, complex and highly regulated processes, sourcing and procurement challenges, and difficulty balancing supply and demand can make overall orthopedic complexity more than the sum of its parts.…
The Link Between Quality, Distribution, and Growth for Pharma Devices Poised on the brink of Q2, we’re seeing signs of hope ahead. This is good news, as the last year has been difficult for everyone. Undeniably, it’s been a year of reckoning for the medtech industry. Pharmaceutical device manufacturers (and other medtech OEMs) are still…
How to Shift from Reactive to Proactive Mode in Pharma Device Distribution If you work in pharmaceutical device manufacturing—or in almost any medical manufacturing—you already know how disrupted a time we find ourselves in. We’re in the midst of an unprecedented period of upheaval as OEMs look to build supply chain resilience, address…
Facing the Biggest Risks of the Pharma Device Supply Chain If 2020 was the year of reckoning for medtech supply chains, 2021 will need to be the year of resilience. We recently delved into the vulnerabilities revealed in these supply chains, noting how a perfect storm created unprecedented pressure on firms to address resilience…
The Supply Chain Reckoning for the Med Device Industry An unprecedented year is coming to a close. Among many other things, it’s been the year of supply chain reckoning in the medtech industry. The first warnings came in February as shutdowns in China created pressure on sourcing, and the disruption only…
Managing Supply Chain Risk in Your COVID-19 Recovery As the pandemic has unfolded over the last eight months, it has brought to light supply chain vulnerabilities across industries. Some have been temporary as suppliers adjust to increased demand. Others have more wide-ranging consequences as they create disruption or significantly lengthen lead times. …